Reduced Intensity Conditioning (Fludarabine and Busulfan) for Allogeneic Hematopoietic Cell Transplantation in Patients with Severe Aplastic Anemia

被引:0
作者
Chilkulwar, Abhishek [1 ]
Sadashiv, Santhosh [2 ]
Khan, Cyrus [2 ]
Fazal, Salman [2 ]
Mewawalla, Prerna [1 ]
Kaminsky, Anna [1 ]
Berteotti, Gina [2 ]
Padhi, Parikshit [2 ]
Lister, John [2 ]
机构
[1] Allegheny Hlth Network Canc Inst, Hematol & Cellular Therapy, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Western Penn Canc Inst, Pittsburgh, PA USA
关键词
D O I
10.1016/j.bbmt.2016.12.163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
358
引用
收藏
页码:S264 / S265
页数:2
相关论文
共 50 条
[21]   Severe fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case report [J].
Annaloro, Claudio ;
Costa, Antonella ;
Fracchiolla, Nicola S. ;
Mometto, Gabriella ;
Artuso, Silvia ;
Saporiti, Giorgia ;
Tagliaferri, Elena ;
Grifoni, Federica ;
Onida, Francesco ;
Cortelezzi, Agostino .
CLINICAL CASE REPORTS, 2015, 3 (07) :650-655
[22]   Rabbit ATG Plus Cyclophosphamide with or without Fludarabine Is Superior Conditioning Regimen for Patients with Severe Aplastic Anemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J].
Ahmed, Parvez ;
Satti, Tariq Mahmood ;
Chaudhry, Qamar Un Nisa ;
Mehmood, Kamran ;
Shahbaz, Nighat ;
Khan, Mehreen Ali ;
Ghafoor, Tariq ;
Iftikhar, Raheel ;
Satti, Humayoon ;
Hanif, Andleeb .
BLOOD, 2016, 128 (22)
[23]   Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia [J].
B George ;
V Mathews ;
A Viswabandya ;
M L Kavitha ;
A Srivastava ;
M Chandy .
Bone Marrow Transplantation, 2007, 40 :13-18
[24]   Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia [J].
George, B. ;
Mathews, V. ;
Viswabandya, A. ;
Kavitha, M. L. ;
Srivastava, A. ;
Chandy, M. .
BONE MARROW TRANSPLANTATION, 2007, 40 (01) :13-18
[25]   Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients [J].
Dai, Zhiming ;
Liu, Jie ;
Zhang, Wang-Gang ;
Cao, Xingmei ;
Zhang, Yang ;
Dai, Zhijun .
MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) :667-671
[26]   Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen [J].
Delgado, Julio ;
Marco, Ana ;
Moreno, Estela ;
Pinana, Jose L. ;
Valcarcel, David ;
Parody, Rocio ;
Sanchez-Gonzalez, Blanca ;
Martino, Rodrigo ;
Briones, Javier ;
Sureda, Anna ;
Brunet, Salut ;
Sierra, Jorge .
BLOOD, 2007, 110 (11) :306B-306B
[27]   Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies [J].
Kennedy, Vanessa E. ;
Savani, Bipin N. ;
Greer, John P. ;
Kassim, Adetola A. ;
Engelhardt, Brian G. ;
Goodman, Stacey A. ;
Sengsayadeth, Salyka M. ;
Chinratanalab, Wichai ;
Jagasia, Madan H. .
BLOOD, 2015, 126 (23)
[28]   Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen [J].
Delgado, J. ;
Marco, A. ;
Moreno, E. ;
Pinana, J. L. ;
Valcarcel, D. ;
Martino, R. ;
Briones, J. ;
Sureda, A. ;
Brunet, S. ;
Sierra, J. .
CYTOTHERAPY, 2009, 11 (03) :356-361
[29]   Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation [J].
E Mohanan ;
J C Panetta ;
K M Lakshmi ;
E S Edison ;
A Korula ;
N A Fouzia ;
A Abraham ;
A Viswabandya ;
V Mathews ;
B George ;
A Srivastava ;
P Balasubramanian .
Bone Marrow Transplantation, 2017, 52 :977-983
[30]   Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation [J].
Mohanan, E. ;
Panetta, J. C. ;
Lakshmi, K. M. ;
Edison, E. S. ;
Korula, A. ;
Fouzia, N. A. ;
Abraham, A. ;
Viswabandya, A. ;
Mathews, V. ;
George, B. ;
Srivastava, A. ;
Balasubramanian, P. .
BONE MARROW TRANSPLANTATION, 2017, 52 (07) :977-983